Literature DB >> 24820626

Dopamine D₁-D₂ receptor heteromer regulates signaling cascades involved in addiction: potential relevance to adolescent drug susceptibility.

Melissa L Perreault1, Brian F O'Dowd, Susan R George.   

Abstract

Adolescence is a developmental period that has been associated with heightened sensitivity to psychostimulant-induced reward, thus placing adolescents at increased risk to develop drug addiction. Although alterations in dopamine-induced synaptic plasticity are perhaps the most critical factor in mediating addiction processes, developmental differences in the cell signaling mechanisms that contribute to synaptic plasticity, and their contribution to adolescent reward sensitivity, has been grossly understudied. The most abundant dopamine receptors, the D1 and D2 receptors, as well as the dopamine D1-D2 receptor heteromer, exhibit age-dependent and brain region-specific changes in their expression and function and are responsible for regulating cell signaling pathways known to significantly contribute to the neurobiological mechanisms underlying addiction. The D1-D2 receptor heteromer, for instance, has been associated with calcium calmodulin kinase IIα, brain-derived neurotrophic factor and glycogen synthase kinase 3 (GSK-3) signaling, three proteins highly implicated in the regulation of glutamate transmission and synaptic plasticity and which regulate addiction to amphetamine, opioids and cocaine. Therefore, in this review the importance of these signaling proteins as potential mediators of addiction susceptibility in adolescence will be highlighted, and the therapeutic potential of the D1-D2 receptor heteromer in addiction will be discussed. It is the overall goal of this review to draw attention to the research gap in dopamine-induced cell signaling in the adolescent brain--knowledge that would provide much-needed insights into adolescent addiction vulnerability.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24820626     DOI: 10.1159/000360158

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  7 in total

1.  Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood.

Authors:  Luke K Sherrill; Joshua M Gulley
Journal:  Brain Res       Date:  2018-05-21       Impact factor: 3.252

Review 2.  The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural-glial networks.

Authors:  Dasiel O Borroto-Escuela; Luigi F Agnati; Karl Bechter; Anders Jansson; Alexander O Tarakanov; Kjell Fuxe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

3.  PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor.

Authors:  Andrew V Dix; Jennie L Conroy; Kara M George Rosenker; David R Sibley; Daniel H Appella
Journal:  ACS Med Chem Lett       Date:  2015-03-13       Impact factor: 4.345

4.  Dopamine Promotes Motor Cortex Plasticity and Motor Skill Learning via PLC Activation.

Authors:  Mengia-Seraina Rioult-Pedotti; Ana Pekanovic; Clement Osei Atiemo; John Marshall; Andreas Rüdiger Luft
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 5.  Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous System.

Authors:  William T Carrick; Brandi Burks; Murray J Cairns; Jannet Kocerha
Journal:  Front Mol Biosci       Date:  2016-10-25

Review 6.  Pharmacology of Ultrasonic Vocalizations in adult Rats: Significance, Call Classification and Neural Substrate.

Authors:  Stefan M Brudzynski
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

7.  Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviors.

Authors:  Ahmed Hasbi; Tuan Nguyen; Haneen Rahal; Joshua D Manduca; Sharon Miksys; Rachel F Tyndale; Bertha K Madras; Melissa L Perreault; Susan R George
Journal:  Biol Sex Differ       Date:  2020-02-22       Impact factor: 5.027

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.